Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Development of a Patient Journey Map for Metabolic Dysfunction-Associated Steatohepatitis: A Comprehensive Assessment of the Patient Journey in North America.
Journal: Journal of patient experience
Published: August 26, 2025
Effect of background asthma and atopic conditions on prophylaxis and treatment of COVID-19 infection.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: August 04, 2025
Effect of background asthma and allergic conditions on prophylaxis and treatment of COVID-19 infection.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: August 04, 2025
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
Journal: Science translational medicine
Published: November 06, 2024
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities.
Journal: Infectious diseases and therapy
Published: May 02, 2024
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19.
Journal: Journal of the Pediatric Infectious Diseases Society
Published: April 19, 2024
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2024
Thematic analysis to explore patients' experiences with long COVID-19: a conceptual model of symptoms and impacts on daily lives.
Journal: BMJ open
Published: January 17, 2024
The symptoms evolution of long COVID‑19 (SE-LC19): a new patient-reported content valid instrument.
Journal: Journal of patient-reported outcomes
Published: September 25, 2023
Blocking common γ chain cytokine signaling ameliorates T cell-mediated pathogenesis in disease models.
Journal: Science translational medicine
Published: January 11, 2023
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
Journal: Scientific reports
Published: December 21, 2022
Last Updated: 09/26/2026